Global Clinical Trial Decentralization Platforms Market 2026-2030
상품코드:1937596
리서치사:TechNavio
발행일:2026년 02월
페이지 정보:영문 295 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 임상시험 분산화 플랫폼 시장은 2025년부터 2030년까지 80억 2,600만 달러 증가하고, 예측 기간 동안 CAGR은 14.4%로 예측됩니다.
세계의 임상시험 분산화 플랫폼 시장에 대해 조사분석했으며, 시장 규모와 예측, 동향, 성장요인, 과제, 25개 벤더 분석 등의 정보를 전해드립니다.
본 보고서는 현재 시장 상황, 최신 동향 및 촉진요인, 시장 환경 전반에 대한 최신 분석을 제공합니다. 시장 성장은 분산형 프레임워크를 통한 환자 접근성 및 다양성 향상, 첨단 웨어러블 기술 및 실시간 데이터 모니터링의 보급, 규제 가이드라인의 진화, 전 세계 시험 기준의 조화에 의해 촉진되고 있습니다.
이번 조사는 업계 주요 관계자들의 정보를 포함한 1차 정보와 2차 정보의 객관적인 조합을 통해 이루어졌습니다. 이 보고서에는 주요 기업 분석과 함께 종합적인 시장 규모 데이터, 지역별 분석과 함께 부문 및 공급업체 현황이 포함되어 있습니다. 보고서에는 과거 데이터와 예측 데이터가 수록되어 있습니다.
시장 범위
기준 연도
2026년
종료 연도
2030년
예측 기간
2026-2030년
성장 모멘텀
가속
전년비 2026년
13.8%
CAGR
14.4%
증가액
80억 2,600만 달러
이 보고서는 향후 몇 년간 세계 임상시험 분산화 플랫폼 시장의 성장을 주도할 주요 요인 중 하나로 환자 모집 및 유지 관리를 강화하기 위한 AI의 통합을 꼽았습니다. 또한, 하이브리드 시험 모델의 확대, 표준화된 데이터 조화, 고정밀 원격 환자 모니터링 및 웨어러블 기술의 도입은 시장에서 상당한 수요를 창출할 것으로 예상됩니다.
목차
제1장 주요 요약
제2장 Technavio 분석
제3장 시장 구도
제4장 시장 규모
제5장 시장 규모 실적
제6장 정성 분석
제7장 Five Forces 분석
제8장 시장 세분화 : 구성요소별
제9장 시장 세분화 : 최종사용자별
제10장 시장 세분화 : 전개별
제11장 고객 상황
제12장 지역별 상황
제13장 촉진요인, 과제, 기회
제14장 경쟁 구도
제15장 경쟁 분석
제16장 부록
KSM
영문 목차
영문목차
The global clinical trial decentralization platforms market is forecasted to grow by USD 8026.0 mn during 2025-2030, accelerating at a CAGR of 14.4% during the forecast period. The report on the global clinical trial decentralization platforms market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by enhancing patient accessibility and diversity through decentralized frameworks, proliferation of advanced wearable technology and real time data monitoring, evolution of regulatory guidelines and global harmonization of trial standards.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Market Scope
Base Year
2026
End Year
2030
Series Year
2026-2030
Growth Momentum
Accelerate
YOY 2026
13.8%
CAGR
14.4%
Incremental Value
$8026.0 mn
Technavio's global clinical trial decentralization platforms market is segmented as below:
By Component
Software
Services
By End-User
Pharmaceutical companies
Contract research organizations
Biotechnology companies
Academic and research institutes
By Deployment
Cloud based platforms
Hybrid deployment
On premises solutions
Geography
North America
US
Canada
Mexico
Europe
Germany
UK
France
Italy
The Netherlands
Spain
APAC
China
India
Japan
Australia
South Korea
Indonesia
South America
Brazil
Argentina
Colombia
Middle East and Africa
South Africa
UAE
Turkey
Rest of World (ROW)
This study identifies the integration of AI for enhanced patient recruitment and retention as one of the prime reasons driving the global clinical trial decentralization platforms market growth during the next few years. Also, expansion of hybrid trial models and standardized data harmonization and implementation of high fidelity remote patient monitoring and wearable technology will lead to sizable demand in the market.
The report on the global clinical trial decentralization platforms market covers the following areas:
Global clinical trial decentralization platforms market sizing
Global clinical trial decentralization platforms market forecast
Global clinical trial decentralization platforms market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global clinical trial decentralization platforms market vendors that include Advarra Inc., Castor Research Inc., Clinical Ink Inc., Crucial Data Solutions Inc., Florence Healthcare., ICON plc, IQVIA Holdings Inc., KAYENTIS SAS, Laboratory Corp., Lightship, Medable Inc., Medidata, Obvio Health USA Inc., Parexel International Corp., Reify Health, Science 37 Inc., Signant Health, Thermo Fisher Scientific Inc., Veeva Systems Inc., YPrime LLC. Also, the global clinical trial decentralization platforms market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market by Geography
Executive Summary - Chart on Market Segmentation by Component
Executive Summary - Chart on Market Segmentation by End-user
Executive Summary - Chart on Market Segmentation by Deployment
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
2.3 Factors of disruption
2.4 Impact of drivers and challenges
3 Market Landscape
3.1 Market ecosystem
3.2 Market characteristics
3.3 Value chain analysis
4 Market Sizing
4.1 Market definition
4.2 Market segment analysis
Market segments
4.3 Market size 2025
4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
5.1 Global Clinical Trial Decentralization Platforms Market 2020 - 2024
Historic Market Size - Data Table on Global Clinical Trial Decentralization Platforms Market 2020 - 2024 ($ million)
